Advertisement

 

 

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
Author Information (click to view)

Crowson CS, Rollefstad S, Kitas GD, van Riel PL, Gabriel SE, Semb AG, ,


Crowson CS, Rollefstad S, Kitas GD, van Riel PL, Gabriel SE, Semb AG, , (click to view)

Crowson CS, Rollefstad S, Kitas GD, van Riel PL, Gabriel SE, Semb AG, ,

Advertisement

PloS one 2017 03 2312(3) e0174656 doi 10.1371/journal.pone.0174656
Abstract
OBJECTIVE
Cardiovascular disease (CVD) risk calculators designed for use in the general population do not accurately predict the risk of CVD among patients with rheumatoid arthritis (RA), who are at increased risk of CVD. The process of developing risk prediction models involves numerous issues. Our goal was to develop a CVD risk calculator for patients with RA.

METHODS
Thirteen cohorts of patients with RA originating from 10 different countries (UK, Norway, Netherlands, USA, Sweden, Greece, South Africa, Spain, Canada and Mexico) were combined. CVD risk factors and RA characteristics at baseline, in addition to information on CVD outcomes were collected. Cox models were used to develop a CVD risk calculator, considering traditional CVD risk factors and RA characteristics. Model performance was assessed using measures of discrimination and calibration with 10-fold cross-validation.

RESULTS
A total of 5638 RA patients without prior CVD were included (mean age: 55 [SD: 14] years, 76% female). During a mean follow-up of 5.8 years (30139 person years), 389 patients developed a CVD event. Event rates varied between cohorts, necessitating inclusion of high and low risk strata in the models. The multivariable analyses revealed 2 risk prediction models including either a disease activity score including a 28 joint count and erythrocyte sedimentation rate (DAS28ESR) or a health assessment questionnaire (HAQ) along with age, sex, presence of hypertension, current smoking and ratio of total cholesterol to high-density lipoprotein cholesterol. Unfortunately, performance of these models was similar to general population CVD risk calculators.

CONCLUSION
Efforts to develop a specific CVD risk calculator for patients with RA yielded 2 potential models including RA disease characteristics, but neither demonstrated improved performance compared to risk calculators designed for use in the general population. Challenges encountered and lessons learned are discussed in detail.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 × 5 =

[ HIDE/SHOW ]